1. Home
  2. NBIX vs DECK Comparison

NBIX vs DECK Comparison

Compare NBIX & DECK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

N/A

Current Price

$154.27

Market Cap

15.5B

Sector

Health Care

ML Signal

N/A

Logo Deckers Outdoor Corporation

DECK

Deckers Outdoor Corporation

N/A

Current Price

$89.20

Market Cap

12.4B

ML Signal

N/A

Company Overview

Basic Information
Metric
NBIX
DECK
Founded
1992
1973
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Shoe Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
15.5B
12.4B
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
NBIX
DECK
Price
$154.27
$89.20
Analyst Decision
Strong Buy
Buy
Analyst Count
22
23
Target Price
$180.91
$122.45
AVG Volume (30 Days)
1.4M
2.2M
Earning Date
05-05-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
41.95
10.90
EPS
3.30
0.94
Revenue
$161,626,000.00
$5,472,296,000.00
Revenue This Year
$24.73
$11.16
Revenue Next Year
$13.14
$6.96
P/E Ratio
$46.38
$97.96
Revenue Growth
977.51
9.76
52 Week Low
$122.14
$78.91
52 Week High
$186.12
$125.45

Technical Indicators

Market Signals
Indicator
NBIX
DECK
Relative Strength Index (RSI) 42.70 37.21
Support Level $152.67 N/A
Resistance Level $161.29 $105.61
Average True Range (ATR) 3.72 2.36
MACD -0.44 -0.16
Stochastic Oscillator 44.08 8.83

Price Performance

Historical Comparison
NBIX
DECK

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About DECK Deckers Outdoor Corporation

Founded in 1973, California-based Deckers designs and sells casual and performance footwear, apparel, and accessories. In fiscal 2026, Ugg and Hoka accounted for 50% and 47% of total sales, respectively. The firm also markets a niche sandal brand Teva. Deckers produces most of its sales through wholesale partnerships but also operates e-commerce in more than 50 countries and has more than 200 company-operated stores, about half of which are outlets. The firm generated 58% of its fiscal 2026 sales in the United States.

Share on Social Networks: